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Recent  study  demonstrated  a close  relationship  between  cerebellum  atrophy  and symptom  severity  of
pediatric  maltreatment-related  posttraumatic  stress  disorder  (PTSD).  It  has  also  been  known  that  females
are more  vulnerable  than  males  in  developing  anxiety  disorders  after  exposure  to  traumatic  stress.  The
mechanisms  are  unknown.  Because  cannabinoid  receptors  (CB1 and  CB2)  are  neuroprotective  and  highly
expressed  in the  cerebellum,  we investigated  cerebellar  CB  expression  in  stressed  rats.  Young  male  and
female  Sprague-Dawley  rats  were  given  40 unpredictable  electric  tail-shocks  for  2 h  daily  on 3  consecu-
tive days.  CB1 and  CB2 mRNA  and  protein  levels  in rat cerebellum  and  brain  stem  were  determined  using
quantitative  real-time  PCR  and  Western  blot,  respectively.  Two-way  ANOVA  revealed  significant  gen-
der and  stress  effects  on cerebellar  CB1 mRNA  expression,  with  females  and  non-stressed  rats  exhibiting
higher  CB1 mRNA  levels  than  the  males  (3  fold,  p < 0.01)  and  stressed  rats  (30%,  p < 0.01),  respectively.  CB1
and  CB2 mRNA  levels  in  brain  stem  were  also  greater  in  female  rats  than  males  (p  < 0.01,  p <  0.05,  respec-
tively).  Repeated  stress  increased  the  level  of  phosphorylated  CB1 receptors,  the  inactivated  CB1, in rat
cerebellum  (p  < 0.01),  particularly  in  female  rats  as  revealed  by  the  significant  gender  ×  stress  interaction.
Thus,  repeated  severe  stress  caused  greater  CB1 mRNA  suppression  and  CB1 receptor  phosphorylation  in
female cerebellum  that could  lead  to  increased  susceptibility  to stress-related  anxiety  disorders  including
PTSD.
© 2011 Elsevier Ireland Ltd. All rights reserved.
Mounting evidence implicates a critical role of cannabinoid
receptors (CB1 and CB2) in stress-related anxiety disorders and
emotional memory. CB1 knockout animals show hypersensitivity
to stressful stimuli, decreased sociability, increased aggressive and
anxiety-like behaviors and disrupted response to anxiolytic drugs
[19,28,46]. CB1 knockout animals and CB1 antagonist-treated ani-
mals also show marked inability to extinguish fear memory [27].
These characteristics parallel the core clinical features of indi-
viduals with post-traumatic stress disorder (PTSD), i.e. reduced
threshold of fear, impaired extinction of fear memory, vivid recall
or flashbacks of traumatic memories and a high prevalence of
cannabis abuse [23,36,49].
Despite the highest expression of cannabinoid receptors (CB1
and CB2) found in the cerebellum [20,25,48],  its functional role
remains to be established. To our knowledge, no one has reported
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cerebellar cannabinoid receptor expression under stressed condi-
tions.
It is known that females are more vulnerable to traumatic stress
and show a higher prevalence of stress-related anxiety disorders
than males (2–3 fold) [7,39].  Yet many animal model studies of
stress are based on male animals only; the generalizability of the
male animal-based findings for females is limited accordingly. In
this study, we  examined CB1 and CB2 expression levels in the cere-
bellum and brain stem of young adult male and female rats, and
the responses to repeated tail-shock stress.
Young juvenile male and female Sprague-Dawley rats (Taconic
Farms, Germantown, NY, USA) weighing 100–150 g (5–6 weeks
old) were unisex and pair-housed, with wood chip bedding, and
maintained at a room temperature of 22 ± 2 ◦C on a 12-h light-dark
schedule (lights on 1800 h), and left undisturbed for 7 days before
the start of the stress protocol that consisted of one 2-h per day ses-
sion of restraint immobilization stress plus unpredictable repeated
tail-shocks over 3 consecutive days. The animals were restrained
in a Plexiglas tube and given 40 electric shocks (2 mA,  3 s dura-
tion) at varying intervals (140–180 s). Animals in the control group
were handled daily as those in the stress group, but without going
through the stress procedure.
0304-3940/$ – see front matter ©  2011 Elsevier Ireland Ltd. All rights reserved.
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After the last stress session on day 3, both the control animals
and the stressed animals were decapitated after light anesthesia
with halothane. The brains were rapidly removed, dissected and
kept at −70 ◦C for real-time PCR and western blotting (Appendix
1). Half of the dissected cerebellum and brain stem of each animal
were homogenized for total RNA extraction with RNeasy kit (Qia-
gen) and reverse transcription into first-strand cDNA with a reverse
transcriptase kit (Sigma, St. Louis).
The qPCR and western blot data were represented as mean ± s.d.
The effects of gender and repeated stress on CB1 and CB2 receptor
expression and phosphorylation in cerebellum and brain stem were
analyzed using two-way ANOVA. As significant gender × stress
interactions were found in CB1 mRNA expression and receptor
phosphorylation, one-way ANOVA was conducted to evaluate the
effect of stress within each sex. p < 0.05 was considered statistically
significant.
The qPCR data showed that CB1 mRNA levels were much higher
than CB2 mRNA in the cerebellum and brain stem of both male and
female control rats as shown by the CB1:CB2 mRNA ratio (>30 fold)
based on the Ct values of each receptor (Appendix 2). This is con-
sistent with previous findings of high CB1 expression in cerebellum
[20].
Two-way ANOVA revealed significant main effects of gender
(p < 0.01) and repeated stress (p < 0.01), as well as significant gen-
der × stress interaction (p < 0.01) on CB1 mRNA expression in rat
cerebellum, with females and non-stressed rats exhibited higher
CB1 mRNA levels than the males (3 fold) and stressed rats (30%),
respectively (Fig. 1A). The significant gender × stress interaction
suggests a greater stress-induced reduction of CB1 mRNA in the
female cerebellum (p < 0.01) than in males (p < 0.05) as revealed by
the within-sex 1-way ANOVA (Fig. 1A). Two-way ANOVA showed
significant gender, but no stress effect on CB1 mRNA expression
level in the brain stem, with female rats showing higher level than
male rats (p < 0.01) (Fig. 1B). CB2 mRNA expression level tended
to be greater in the cerebellum and significantly greater in the
brain stem (p < 0.05) of female rats than males (Fig. 1C and D). No
significant stress effect was found in brain stem CB2 mRNA.
No significant gender and stress effects were found on total
CB1 and CB2 proteins expressed in rat cerebellum and brain stem
(Figs. 2 and 3). However, phosphorylated CB1 receptor (p-CB1),
the inactivate form of CB1 receptors, was significantly increased
in the cerebellum of the stressed rats (2-way ANOVA, p < 0.01),
especially in the stressed females (Fig. 2A). Further, a significant
stress × gender interaction existed in cerebellar p-CB1 protein level
suggesting a greater p-CB1 level in the female cerebellum as sup-
ported by the within-sex 1-way ANOVA (p < 0.01) (Fig. 2A). Because
CB1 receptor phosphorylation has been shown to be associated with
increased internalization and desensitization of CB1 receptors [18],
the increased p-CB1 receptors suggest increased inhibition of CB1
receptor activity in the cerebellum of stressed animals.
The gender difference in cerebellar CB1 and CB2 mRNA expres-
sion is consistent with the reports of greater endocannabinoid
content in the brains of female rats [5] and a greater CB1 mRNA
expression in the blood cells of female human subjects [34].
Gender differences have also been reported in the amount of
self-administered CB1 agonists, in brain metabolism and behav-
ioral effects of 9-tetrahydrocannabinol (9-THC, the main active
component of marijuana and potent CB1 agonist) in rodents,
with females self-administering more CB1 agonists, producing sig-
nificantly more of the active metabolite of THC and enhanced
THC-induced behavioral effects including antinociception, motoric
effects, catalepsy and hypothermia [10,16,33,44,45]. Although the
mechanism is unknown, sex hormones and the estrous cycle may
be involved in the gender difference in CB1 and CB2 receptor
expression. There are reports that ovariectomy (OVX) decreased,
whereas acute and chronic estradiol or progesterone administra-
tion increased the density of cannabinoid receptors in the limbic
forebrain and in the hypothalamic nucleus of intact and OVX female
rats [40]. As the present female rats were in the pubertal stage and
their estrous cycles were not controlled, this could have poten-
tially contributed to the higher variability in CB1 and CB2 receptor
expression in the female brain.
The higher CB1 mRNA expression levels but lower CB1 protein
expression levels in the brain stem of females than males sug-
gest a differential regulation of CB1 mRNA and protein expression
between the sexes. While the mechanism is unknown, a poten-
tially greater turnover/degradation rate of CB1 receptor protein in
the females could have triggered a need for greater CB1 mRNA
expression. Differential modification of the CB receptor (phos-
phorylation, glycosylation) induced by sex hormones could cause
sex-dependent changes in the affinity and immunogenic activity
of CB receptors as detected by the antibodies in this study and
others [14]. Furthermore, the greater metabolic rate of cannabi-
noids reported in the females could cause a parallel increase in CB1
protein turnover and CB1 mRNA expression.
A difference in circulating corticosterone level could also be
responsible for the observed sex-dimorphism in CB1 mRNA expres-
sion. It is known that females have higher basal corticosteroid levels
and greater stress-induced corticosteroid secretion but slower cor-
ticosteroid clearance from circulation [8,9]. Chronic exposure to
corticosterone, CB1 agonists and cannabinoids has been shown to
downregulate CB1 receptor density, CB1 receptor binding and CB1
mRNA expression in brain regions such as cerebellum and hip-
pocampus [15,22,26,37,41].
Although no significant stress effect was found in CB expres-
sion in brain stem, this may  reflect the technical limitations of
present study. Because brain stem tissue homogenates were used
in this study, the results are not conclusive regarding changes in
CB receptor expression in specific nuclei of the brain stem. Further
immunohistochemistry/in situ hybridization studies are required
to determine specific changes in cannabinoid receptor expression
in these nuclei after stress and their correlations with behavioral
changes in PTSD models. Cannabinoid receptors expressed in the
periaqueductal gray, locus coeruleus, raphe nuclei, reticular acti-
vating system, solitary tract, vestibular and cochlear nuclei of brain
stem are thought to play important roles in the regulation of pain
sensation, sleep-awake cycle, acoustic startle response, cardiovas-
cular reactivity that are frequently altered in subjects with PTSD
[1,2,12,30–32,38,48].
Since stress enhances norepinephrine (NE) synthesis/turnover
in the LC and its subsequent release in the basolateral amygdala via
alpha1A adrenergic receptor located in the presynaptic terminals,
intense sympathetic activation and local NE release could regu-
late CB expression/activity via the release of eCBs. Alternatively,
CB1 receptors in the brain stem could potentially interacts with
the alpha2-adrenergic autoreceptors to inhibit norepinephrine
release from the adrenergic neurons of the locus coeruleus under
physiological conditions [42]. Our studies show that the stress dif-
ferentially suppressed brain adrenergic receptor mRNA expression
between male and female rats, with a sex-dimorphism opposing
that of brain CB mRNA expression (manuscript in preparation).
Thus, brain CB and adrenergic systems could interact in central
regulation of cardiovascular response in stress-induced anxiety dis-
orders [6].
A  recent study showed that acute maternal deprivation signif-
icantly increased neuronal apoptosis in the cerebellum of male
rat pups and that induction was attenuated by inhibiting endoge-
nous cannabinoid (eCBs) degradation [24]. As brain eCBs activity
is mainly mediated by CB1 receptors, that study implicates an
important anti-apoptosis role of CB1 receptor in stressed cerebel-
lum. Another brain imaging study showed significant correlations
between structural volumes of the cerebellar hemispheres and clin-
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Fig. 1. Effects of gender and stress on CB1 and CB2 mRNA. (A), Cerebellar CB1 mRNA level was significantly higher in the female rats (n = 16) than in the males (n = 16, p < 0.01)
and  in the non-stressed animals (n = 16) than in the stressed animals (n = 16, p < 0.01), respectively. Three days repeated stress down-regulated CB1 mRNA level in male
(p  < 0.05) and female rats (p < 0.01) when compared with same sex controls; (B), Brain stem CB1 mRNA was significantly greater in female rats than in male rats (p < 0.01) but
no  stress effect was  found; (C), Cerebellar CB2 mRNA was  not affected by sex or stress; (D), Brain stem CB2 mRNA level was significantly higher in female rats than in the
males  (p < 0.05). The mean value of the male control group (mean ± s.d.) was  used as the arbitrary reference (=1). Black column: control rats; gray column, stressed rats, a,
p  < 0.01, male control vs. female control; b, p < 0.05, male control vs. female control; *p < 0.05; **p < 0.01, within-sex 1-way ANOVA.
Fig. 2. Western blotting of CB proteins in rat cerebellum. Top panel, representatives of cerebellum western blotting: twenty micrograms (g) of rat cerebellum tissue
homogenates were resolved on SDS-PAGE gel and incubated with the specific CB antibodies and detected using an ECL western blot detecting system. Bottom pane, (A),
phosphorylated CB1 proteins (p-CB1); (B), semi-quantitative western blotting of total CB1 proteins; (C), CB2 proteins and; (C) in rat cerebellar tissue homogenates with or
without  3 days repeated tail-shock stress. The mean value (mean ± s.d.) of the male control group (n = 8) was used as the arbitrary reference (=1) for other groups (n = 8).
Two-way ANOVA revealed significantly elevated p-CB1 protein in the stressed animals, primarily in the females, *p < 0.05; Black column, control group; gray column, stress
group  (n = 8 each group).
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Fig. 3. Western blotting of CB proteins in rat brain stem. Top panel, representatives of cerebellum western blotting: twenty micrograms (g) of rat brain stem tissue
homogenates were resolved on SDS-PAGE gel and incubated with the specific CB primary antibodies and detected using an ECL western blot detecting system. Bottom panel,
semi-quantitative western blotting of: (A) phosphorylated CB1 proteins (p-CB1); (B) total CB1 proteins and; (C) CB2 proteins in rat brain stem tissue homogenates with or
without 3 days repeated tail-shock stress. The mean value (mean ± s.d.) of the male control group (n = 8) was used as the arbitrary reference (=1) for other groups (n = 8).
Black  column: control group; gray column, stressed group.
ical symptoms in pediatric maltreatment-related PTSD. The PTSD
subjects had significantly reduced volume in both the left and
the right hemispheres and in total cerebellum volume [11]. These
studies implicate a link between stress-induced apoptosis and cere-
bellum atrophy in PTSD although the exact causative factors and
the time course of the atrophy remain to be established. Our study
suggests that chronic stress-induced CB1 receptor suppression in
early development could be involved in the cerebellar neuronal
apoptosis or structural atrophy in PTSD.
It is known that females are more vulnerable than males after
exposure to trauma [4,28].  The molecular mechanism is unknown.
In this study, the stressed female rats showed a greater reduction
in CB1 mRNA expression but a greater increase in cerebellum CB1
receptor phosphorylation (at serine 316) than the stressed males.
Because phosphorylation at serine 316 of CB1 receptor by protein
kinase C is a key post-translational regulatory mechanism under-
lying rapid CB1 receptor internalization and desensitization by
disrupting cannabinoids-mediated activation of inwardly rectify-
ing potassium current and depression of P/Q-type calcium channels
x [18], this phosphorylation of CB1 receptors would represent
another novel mechanism of rapid CB1 inhibition in the cerebel-
lum of stressed female rats. Other studies suggest that it is the rate
of change rather than absolute level that can bring about swings in
mood and anxiety.
It is tempting to speculate that chronic stress-induced CB1
receptor downregulation and inhibition could also be involved
in increased marijuana use and cerebellum dysfunction such as
altered time sense in PTSD [47]. While further studies are needed
to evaluate this notion, impaired time sense has been reported in
marijuana users who exhibited cerebellar hypoactivity in response
to delta-9-tetrahydrocannabinol [29]. Because marijuana use is
common among PTSD subjects and is correlated with the severity
of PTSD symptoms [3],  the greatly altered CB1 mRNA expression
and receptor phosphorylation/desensitization in stressed female
cerebellum is consistent with the literature that women  are more
vulnerable to traumatic stress, become drug dependent more
quickly and are more likely to experience craving than men
[4,7,13,17,21,35,43].
In summary, we observed significant gender and repeated stress
effects and their interaction on CB1 mRNA expression and CB1
receptor phosphorylation in rat cerebellum. The greater CB1 mRNA
expression level in female cerebellum is more vulnerable than
that of males after exposure to repeated stress. The rapid CB1
receptor phosphorylation in cerebellum after stress could also be
a biomarker for increased anxiety in females after exposure to
repeated traumatic stress. If replicated, these findings could help
to design gender-specific pharmacological interventions for stress-
induced anxiety disorders.
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